ARCHIVES

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

May 24, 2002

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

The Cancer Letter Stands By Story

October 30, 1998

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

A Transcript: what Fisher Knew, When Did He Know

June 24, 1994